Senti Biosciences (SNTI) Income Statement (2021 - 2026)
Income Statement report data from Mar 31, 2021 to Mar 31, 2026 for Senti Biosciences (SNTI).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||
Total Revenue | 20K (0.00%) | 20K | - | - | - | - | - | - | - | - | 260K (-62.32%) | 690K (-33.65%) | 1.04M | -190.00K | 1.52M (+36.94%) | 1.11M (+30.59%) | 850K (-8.60%) | 930K | - |
Operating Expenses | |||||||||||||||||||
Research And Development | 5.28M (-31.96%) | 7.76M (-26.24%) | 11M (+4.89%) | 10M (+8.08%) | 9.28M (+19.43%) | 7.77M (-10.17%) | 8.65M (-5.46%) | 9.15M (+4.21%) | 8.78M (-3.73%) | 9.12M (+0.33%) | 9.09M (+32.12%) | 6.88M (-2.55%) | 7.06M (+47.70%) | 4.78M (-26.69%) | 6.52M (-29.51%) | 9.25M (+21.71%) | 7.60M (+40.48%) | 5.41M | - |
Selling General And Administrative | 6.23M (+6.50%) | 5.85M (-9.02%) | 6.43M (-5.02%) | 6.77M (-4.92%) | 7.12M (-11.88%) | 8.08M (+23.17%) | 6.56M (+55.82%) | 4.21M (-44.02%) | 7.52M (-19.23%) | 9.31M (-1.27%) | 9.43M (+1.95%) | 9.25M (+0.65%) | 9.19M (+1.10%) | 9.09M (-9.01%) | 9.99M (-28.03%) | 14M (+163.88%) | 5.26M (-26.12%) | 7.12M | - |
Operating Expenses | 4.63M (-75.19%) | 19M (+10.09%) | 17M (+0.89%) | 17M (+2.44%) | 16M (+1.42%) | 16M (+6.24%) | 15M (+13.92%) | 13M (-18.04%) | 16M (-12.83%) | 19M (-57.70%) | 44M (+174.09%) | 16M (-0.74%) | 16M (+17.16%) | 14M (-15.99%) | 17M (-28.62%) | 23M (+79.86%) | 13M (+2.63%) | 13M | - |
Depreciation And Amortization | 690K (-74.54%) | 2.71M | - | - | 930K (-67.37%) | 2.85M | - | - | 980K (-57.21%) | 2.29M | - | 800K (+70.21%) | 470K (+2.17%) | 460K (+15.00%) | 400K (+33.33%) | 300K (+25.00%) | 240K (+20.00%) | 200K | - |
Operating Income | |||||||||||||||||||
Operating Income | -4.62M (-75.21%) | -18.64M (+9.97%) | -16.95M (+0.89%) | -16.80M (+2.44%) | -16.40M (+1.42%) | -16.17M (+6.31%) | -15.21M (+13.85%) | -13.36M (-18.04%) | -16.30M (-12.83%) | -18.70M (-57.38%) | -43.88M (+188.87%) | -15.19M (+1.54%) | -14.96M (+8.33%) | -13.81M (-6.37%) | -14.75M (-32.25%) | -21.77M (+85.12%) | -11.76M (+2.98%) | -11.42M | - |
Ebit | -4.62M (-75.21%) | -18.64M (+9.97%) | -16.95M (+0.89%) | -16.80M (+2.44%) | -16.40M (+1.42%) | -16.17M (+6.31%) | -15.21M (+13.85%) | -13.36M (-18.04%) | -16.30M (-12.83%) | -18.70M (-57.38%) | -43.88M (+188.87%) | -15.19M (+1.54%) | -14.96M (+8.33%) | -13.81M (-6.37%) | -14.75M (-32.25%) | -21.77M (+85.12%) | -11.76M (+2.98%) | -11.42M | - |
EBITDA | -3.93M (-76.62%) | -16.81M (-7.28%) | -18.13M (+23.08%) | -14.73M (-4.78%) | -15.47M (+754.70%) | -1.81M (-93.73%) | -28.87M (+157.77%) | -11.20M (-26.89%) | -15.32M (-66.23%) | -45.36M (+204.02%) | -14.92M (+3.68%) | -14.39M (-0.76%) | -14.50M (+8.61%) | -13.35M (-6.97%) | -14.35M (-33.16%) | -21.47M (+86.37%) | -11.52M (+2.67%) | -11.22M (-46.57%) | -21.00M |
Other Income / Expenses | |||||||||||||||||||
Other Non Operating Income | 200K (-75.00%) | 800K (+263.64%) | 220K (+4.76%) | 210K (+16.67%) | 180K (-10.00%) | 200K | -10.00K | 10K | - | -30.00K (+200.00%) | -10.00K | - | -10.00K (-66.67%) | -30.00K | - | 30K | -50.00K | 20K | - |
Net Income | |||||||||||||||||||
Net Income From Continuing Operations | -4.22M (-70.84%) | -14.47M (-20.19%) | -18.13M (+23.08%) | -14.73M (+4.39%) | -14.11M (+2213.11%) | -610.00K (-97.89%) | -28.87M (+157.77%) | -11.20M (-7.51%) | -12.11M (-35.31%) | -18.72M (+25.47%) | -14.92M (-20.21%) | -18.70M (-0.11%) | -18.72M (+2.80%) | -18.21M (+9.44%) | -16.64M (+44.07%) | -11.55M (-2.20%) | -11.81M (+3.51%) | -11.41M (-45.67%) | -21.00M |
Net Income | -4.22M (-70.84%) | -14.47M (-20.19%) | -18.13M (+23.08%) | -14.73M (+4.39%) | -14.11M (+2213.11%) | -610.00K (-97.89%) | -28.87M (+157.77%) | -11.20M (-7.51%) | -12.11M (-35.31%) | -18.72M (+25.47%) | -14.92M (-20.21%) | -18.70M (-0.11%) | -18.72M (+2.80%) | -18.21M (+9.44%) | -16.64M (+44.07%) | -11.55M (-2.20%) | -11.81M (+3.51%) | -11.41M (-45.67%) | -21.00M |
Comprehensive Income Net Of Tax | -4.22M (-93.13%) | -61.44M (+238.89%) | -18.13M (+23.08%) | -14.73M (+4.39%) | -14.11M (-73.27%) | -52.79M (+82.85%) | -28.87M (+157.77%) | -11.20M (-7.51%) | -12.11M (-82.96%) | -71.06M (+376.27%) | -14.92M (-20.21%) | -18.70M (-0.11%) | -18.72M (-67.84%) | -58.21M (+249.82%) | -16.64M (+44.07%) | -11.55M (-2.20%) | -11.81M (+3.51%) | -11.41M | - |